Trials / Unknown
UnknownNCT01356524
Relationship Between Mid-luteal Serum Progesterone Levels to Pregnancy Rates in Assisted Reproductive Techniques (ART)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Hillel Yaffe Medical Center · Other Government
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
In Assisted Reproductive Techniques (ART) there is a need for luteal support using progesterone, estrogen and probably human chorionic gonadotropin (HCG). The optimal route of administration and dose has not yet been determined. The aim of the study is to investigate whether high levels of mid-luteal serum progesterone are related to higher pregnancy rates in ART cycles. We also plan to investigate whether using higher doses of vaginal progesterone results in higher pregnancy rates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Additional vaginal progesterone | The progesterone dose will be raised from 200 mg daily to 300 mg daily |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2011-05-19
- Last updated
- 2011-05-19
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01356524. Inclusion in this directory is not an endorsement.